ALK inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis.

QR Code

ALK inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis.

<h4>Background</h4>We sought to assess the relative effects of individual anaplastic lymphoma kinase (ALK) inhibitors for the treatment of non-small cell lung cancer (NSCLC).<h4>Methods</h4>We searched MEDLINE, Embase, Cochrane CENTRAL, and grey literature (July 23, 2019) for...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jesse Elliott, Zemin Bai, Shu-Ching Hsieh, Shannon E Kelly, Li Chen, Becky Skidmore, Said Yousef, Carine Zheng, David J Stewart, George A Wells
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-01-01
Series:	PLoS ONE
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0229179&type=printable
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
by: Jesse Elliott, et al.
Published: (2020-01-01)

Modern treatment of ALK-positive non-small cell lung cancer
by: D. A. Kharagezov, et al.
Published: (2022-06-01)

Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung
by: Naoko Imanishi, et al.
Published: (2018-03-01)

Safety of Lorlatinib in Patients with Unresectable Advanced <i>ALK</i>-Positive Non-Small-Cell Lung Cancer Previously Treated with ALK Inhibitors: A Single-Arm, Open-Label, Phase IV Study in India
by: Ullas Batra, et al.
Published: (2025-08-01)

Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study
by: A. S. Kolbin, et al.
Published: (2023-11-01)

Clinicopathological and demographical characteristics of non-small cell lung cancer patients with ALK rearrangements: a systematic review and meta-analysis.
by: Liang Fan, et al.
Published: (2014-01-01)

Successful salvage surgery followed by second ALK–TKI after alectinib failure in a patient with ALK-positive NSCLC
by: Hiroshi Hashimoto, et al.
Published: (2022-04-01)

CLINICAL EFFICACY OF TARGETED THERAPY TOWARDS METASTATIC LUNG CANCER CARRYING DISTINCT TYPES OF ALK REARRANGEMENTS
by: N. V. Mitiushkina, et al.
Published: (2020-09-01)

Structural Analysis of the AlkB Family in Poultry
by: Yuling Niu, et al.
Published: (2025-07-01)

A lung adenocarcinoma patient with EGFR mutation in exon 18 and ALK-rearrangement who treated with erlotinib and crizotinib
by: Mehmet Artaç, et al.
Published: (2018-08-01)

CT-based radiomics integrated model for brain metastases in stage III/IV ALK-positive lung adenocarcinoma patients
by: Fen Wang, et al.
Published: (2025-06-01)

Alectinib-Induced Hemolysis in a Case of ALK-Positive Metastatic Lung Adenocarcinoma: A Case Report with Review of Literature
by: Suparna Ajit Rao, et al.

Correction: CT-based radiomics integrated model for brain metastases in stage III/IV ALK-positive lung adenocarcinoma patients
by: Fen Wang, et al.
Published: (2025-07-01)

Remarkable tumor response to Iruplinalkib in a 14-year-old girl with ALK-positive advanced metastatic non–small-cell lung cancer: a case report
by: Jiahao Wang, et al.
Published: (2025-07-01)

MOLECULAR BIOLOGICAL CHARACTERISTICS OF ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA
by: E. V. Chernyshova, et al.
Published: (2017-01-01)

Successful Treatment of Osimertinib Resistance in an EGFR‐Mutant Lung Cancer Patient With a Rare STRN3‐ALK Fusion Using Brigatinib and Osimertinib
by: Chia‐Yu Kuo, et al.
Published: (2025-07-01)

Early Weight Gain as a Risk Factor for Increased Maximum Weight Gain Among Patients With NSCLC on Lorlatinib and Other ALK Tyrosine Kinase Inhibitors
by: Alexander S. Watson, MD, DPhil, et al.
Published: (2025-09-01)

Beyond VEGF: The NOTCH and ALK1 Signaling Pathways as Tumor Angiogenesis Targets
by: Nolan-Stevaux, Olivier, et al.
Published: (2012)

ALK Family Inhibitor A83-01 Promotes the Proliferation of Mouse Male Germline Stem Cells (mGSCs) Under Serum- and Feeder-Free Conditions
by: Meng YU, et al.
Published: (2013-10-01)

EFFICACY OF TARGET THERAPY WITH CRIZOTINIB IN A PATIENT WITH ALK-POSITIVE ADVANCED GASTRIC CANCER
by: A. A. Paichadze, et al.
Published: (2020-03-01)

Molecular marker-assisted breeding of rice strains with different combinations of Wx and ALK genes
by: Aoqiu FU, et al.
Published: (2025-07-01)

Novel ALK gene mutation in inflammatory myofibroblastic tumor of the thyroid: a case report
by: Yang Guangxu, et al.
Published: (2025-06-01)

Highlights on immune checkpoint inhibitors in non–small cell lung cancer
by: Meng Shen, et al.
Published: (2017-03-01)

Case Report: CAR-T therapy for primary cerebellar ALK-negative anaplastic large cell lymphoma
by: Zhongqing Zou, et al.
Published: (2025-07-01)

Primary mediastinal large B-cell lymphoma with a rare <i>ALK</i> gene mutation
by: O. I. Kit, et al.
Published: (2022-06-01)

Circulating predictive markers of immune checkpoint inhibitors in non-small cell lung cancer
by: A. A. Musaelyan, et al.
Published: (2021-11-01)

Successful use of enteric alectinib in a critically ill patient with metastatic ALK-adenocarcinoma: A case report
by: Maria Braganca, et al.
Published: (2025-12-01)

Activity of alkanmonooxygenase <i>alk</i>B gene in strains of hydrocarbon-oxidizing bacteria isolated from petroleum products
by: T. N. Shapiro, et al.
Published: (2022-10-01)

Primary bone ALK-positive anaplastic large cell lymphoma presented as a giant extraskeletal mass with coagulation necrosis
by: Shuji Nagata, et al.
Published: (2025-09-01)

Cost-effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for Non-small Cell Lung Cancer in Greece
by: George Gourzoulidis, et al.
Published: (2022-02-01)

The effect of telephone support interventions on coronary artery disease (CAD) patient outcomes during cardiac rehabilitation: a systematic review and meta-analysis.
by: Ahmed Kotb, et al.
Published: (2014-01-01)

Effectiveness of terbutaline pump for the prevention of preterm birth. A systematic review and meta-analysis.
by: Laura M Gaudet, et al.
Published: (2012-01-01)

What guidance are researchers given on how to present network meta-analyses to end-users such as policymakers and clinicians? A systematic review.
by: Shannon M Sullivan, et al.
Published: (2014-01-01)

The timber framing book
by: Elliott, Stewart
Published: (1977)

Pathological complete response in synchronous double primary lung squamous carcinoma after neoadjuvant tislelizumab immunotherapy and chemotherapy: A case report
by: Hongming Wang, et al.
Published: (2025-08-01)

SHP2 inhibitor specifically suppresses the stemness of KRAS-mutant non-small cell lung cancer cells
by: Lei Jiang, et al.
Published: (2019-12-01)

Masa auricular como presentación rara de linfoma anaplásico de células grandes, ALK negativo: reporte de un caso
by: Gabriela T. León-Molina, et al.
Published: (2024-07-01)

Comparative effectiveness of different forms of telemedicine for individuals with heart failure (HF): a systematic review and network meta-analysis.
by: Ahmed Kotb, et al.
Published: (2015-01-01)

Evolution of Uniportal Robotic‐Assisted Thoracic Surgery: A Retrospective Study on the Original and Modified Techniques for Lung Anatomic Resections
by: Ching Yang Wu, et al.
Published: (2025-06-01)

Business computing /
by: Skidmore, Steve
Published: (1987)